Saxagliptin, alogliptin, and cardiovascular outcomes

N Engl J Med. 2014 Jan 30;370(5):483. doi: 10.1056/NEJMc1313880.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adamantane / analogs & derivatives*
  • Angina, Unstable / drug therapy*
  • Cardiovascular Diseases / epidemiology*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Dipeptides / therapeutic use*
  • Dipeptidyl-Peptidase IV Inhibitors / therapeutic use*
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Male
  • Myocardial Infarction / drug therapy*
  • Piperidines / therapeutic use*
  • Uracil / analogs & derivatives*

Substances

  • Dipeptides
  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
  • Piperidines
  • Uracil
  • Adamantane